DEFINITIVE HEALTHCARE CORP
DHNASDAQTrading Snapshot
- Day Range
- $0.92 – $0.95
- 52-Week Range
- $0.61 – $4.07
- Volume
- $2.24B
- Avg Volume
- $2.04B
- Shares Outstanding
- 143.8M
- Next Earnings
- Nov 18, 2026
Fundamentals Snapshot
- Annual Revenue
- $242M
- Last Q Revenue
- $55M
- P/E Ratio
- —
- P/S Ratio
- 0.6x
- EPS (TTM)
- $-1.61
- Dividend Yield
- —
- Dilution (1yr)
- −10.1%
Why Investors Own DH
- ✓High-growth profile — revenue up +36.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 69% gross margin and 26% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
DEFINITIVE HEALTHCARE CORP
DH
StockOtter · stockotter.spaceAbout DEFINITIVE HEALTHCARE CORP
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
Financial Review: HealthStream (NASDAQ:HSTM) versus Definitive Healthcare (NASDAQ:DH)
HealthStream (NASDAQ: HSTM - Get Free Report) and Definitive Healthcare (NASDAQ: DH - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on th
Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International
FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry leader in healthcar
Definitive Healthcare Appoints Clay Ritchey as CEO
FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Dire
Definitive Healthcare (NASDAQ:DH) & Certara (NASDAQ:CERT) Financial Comparison
Definitive Healthcare (NASDAQ: DH - Get Free Report) and Certara (NASDAQ: CERT - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on
Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of “Reduce” by Analysts
Definitive Healthcare Corp. (NASDAQ: DH - Get Free Report) has received a consensus rating of "Reduce" from the nine analysts that are covering the firm, Marketbeat.com reports. Three equities research analysts have rate
Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript
Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript